Market Cap: $32.85M
Innovative Partnership Enhances Cancer Diagnostic Capabilities NeoGenomics, Inc., a leading provider of oncology diagnostic solutions, embarks on a transformative collaboration with Ultima Genomics, I…
NeoGenomics Partners with Ultima Genomics to Advance Oncology Diagnostics In a significant development for the oncology diagnostics sector, NeoGenomics, Inc. has announced a strategic collaboration wi…
